Acquiring Company
Gilead Sciences
Acquired Company
Arcellx, Inc
Foster CityGaithersburgBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyDescription
On February 22, 2026, Gilead Sciences, Inc. entered into an Agreement and Plan of Merger with Arcellx, Inc. and its wholly owned subsidiary, Ravens Sub, Inc. This merger will allow Gilead to commence a tender offer to acquire all outstanding shares of Arcellx. The transaction is intended to enhance Gilead's portfolio in oncology and immunology.
Who to call at Gilead Sciences, and when
When Gilead Sciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Gilead Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gilead Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gilead Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gilead Sciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Arcellx, Inc?
Arcellx, Inc was acquired by Gilead Sciences, based in Foster City. The deal was reported on February 23, 2026. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. Gilead Sciences is publicly traded (GILD) and operates in Biotechnology.
When did Gilead Sciences acquire Arcellx, Inc?
Gilead Sciences's acquisition of Arcellx, Inc was reported on February 23, 2026. On February 22, 2026, Gilead Sciences, Inc. entered into an Agreement and Plan of Merger with Arcellx, Inc. and its wholly owned subsidiary, Ravens Sub, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Arcellx, Inc do?
We are a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies. It is privately held, operating in Biotechnology, and is based in Gaithersburg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.